Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk
Adverse events should also be reported to medac drug safety at: drugsafety@medac.de
Support information
Here you will find a growing list of support materials including informative videos and information for patients.
Mitomycin medac – What to expect during your bladder cancer treatment
For patients prescribed Mitomcyin medac
Your BCG-medac treatment guide and record
For patients prescribed BCG-medac
Non-muscle invasive bladder cancer NMIBC
Developed alongside Action Bladder Cancer UK (ABC UK), this booklet has been written as a short introduction to non-muscle invasive bladder cancer – NMIBC (sometimes referred to as early or superficial bladder cancer). It is intended to give you more information following a suspected diagnosis and help you understand the basics of bladder cancer, how it is tested and graded, the main treatment options and where you can find more support.
